You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inhaled glucocorticosteroids

Showing 1 - 25 of 2,115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) MDI
  • Fluticasone propionate/salmeterol (F/SC) DPI
  • (no location specified)
Feb 7, 2022

Asthma Trial (SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID)

Withdrawn
  • Asthma
  • SCH 32088 mometasone furoate (MF) metered-dose inhaler
  • Placebo metered-dose inhaler BID
  • (no location specified)
Feb 7, 2022

Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,

Completed
Has Results
  • Asthma
  • mometasone furoate combination MDI 200/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Asthma Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI))

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) combination
  • Mometasone furoate MDI (MF MDI)
  • (no location specified)
Feb 7, 2022

Asthma Trial (Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol

Completed
Has Results
  • Asthma
  • Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Asthma Trial (mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg,

Completed
Has Results
  • Asthma
  • mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)

Terminated
  • Pulmonary Disease, Chronic Obstructive
  • Bronchodilator Agents
  • Bari, BA, Italy
  • +38 more
Dec 23, 2022

Pulmonary Disease, Chronic Obstructive, Pneumonia, Bacterial Trial in Ann Arbor (Bronchoscopy with bilateral bronchoalveolar

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Pneumonia, Bacterial
  • Bronchoscopy with bilateral bronchoalveolar lavages
  • Ann Arbor, Michigan
    VA Ann Arbor Healthcare System
Apr 26, 2022

Asthma, Cough Variant Asthma Trial in Warsaw (Budesonid or budesonide/fomoterol administered by DPI, Budesonid or

Recruiting
  • Asthma
  • Cough Variant Asthma
  • Budesonid or budesonide/fomoterol administered by DPI
  • Budesonid or budesonide/fomoterol administered by MDI
  • Warsaw, Poland
    Department of Internal Medicine, Pneumonology and Allergology, M
Jul 7, 2021

Factors Influencing on Correctness of Inhalation Technique.

Recruiting
  • Asthma
  • COPD
  • Assessment of correctness of inhaling technique
  • Warsaw, Poland
    Department of Internal Medicine, Pneumonology and Allergology, M
Jul 7, 2021

Bronchial Asthma Trial in Poland, Ukraine (beclomethasone dipropionate plus formoterol fumarate combination, fluticasone

Completed
  • Bronchial Asthma
  • beclomethasone dipropionate plus formoterol fumarate combination
  • fluticasone propionate plus salmeterol xinafoate combination
  • Gdansk, Poland
  • +11 more
Jul 30, 2020

Bronchial Asthma Trial in Austria, Poland, Ukraine (beclomethasone dipropionate plus formoterol fumarate combination, budesonide

Completed
  • Bronchial Asthma
  • beclomethasone dipropionate plus formoterol fumarate combination
  • budesonide plus formoterol combination
  • Wien, Austria
  • +12 more
Jul 30, 2020

Asthma Trial (biological, other, drug)

Withdrawn
  • Asthma
  • Anakinra
  • +2 more
  • (no location specified)
May 12, 2021

Asthma Trial (biological, other, drug)

Withdrawn
  • Asthma
  • Anakinra
  • +2 more
  • (no location specified)
May 5, 2021

Realize the Current Situation of COPD Patients in China

Completed
  • Chronic Obstructive Pulmonary Disease COPD
    • Beijing, China
      Research Site
    Jan 11, 2022

    Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

    Recruiting
    • Asthma
    • To compare in both treatment arms the percentage of patients controlled at week 52.
    • Inca, Baleares, Spain
    • +16 more
    Jun 16, 2023

    Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in

    Recruiting
    • Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
    • Chronic Lung Allograft Dysfunction
    • San Francisco, California
      University of California, San Francisco
    Aug 28, 2023

    Autoimmune Pulmonary Alveolar Proteinosis Trial in Worldwide (Molgramostim, Placebo, PARI eFlow nebulizer system)

    Completed
    Has Results
    • Autoimmune Pulmonary Alveolar Proteinosis
    • Los Angeles, California
    • +29 more
    Dec 14, 2022

    COPD (COPD) Trial in Manchester, Nottingham, Southampton (Interferon Beta-1A, Placebo)

    Completed
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Interferon Beta-1A
    • Placebo
    • Belfast, United Kingdom
    • +15 more
    Jan 3, 2023

    Anaphylactic Reaction Trial in Adelaide (Epinephrine, Placebo)

    Not yet recruiting
    • Anaphylactic Reaction
    • Adelaide, South Australia, Australia
      CMAX Clinical Research
    Aug 22, 2023

    Acute Respiratory Distress Syndrome (ARDS) Trial in Milan, Potenza (Pirfenidone, Placebo)

    Recruiting
    • Acute Respiratory Distress Syndrome (ARDS)
    • Milan, MI, Italy
    • +1 more
    Dec 23, 2022

    COPD Exacerbation, COPD Exacerbation Trial (Furosemide, Normal saline)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease Exacerbation
    • COPD Exacerbation
    • (no location specified)
    Mar 3, 2023

    Suicidal Ideation, MDD, Treatment Resistant Depression Trial in Chicago (Nitrous oxide gas for inhalation, Placebo)

    Not yet recruiting
    • Suicidal Ideation
    • +2 more
    • Nitrous oxide gas for inhalation
    • Placebo
    • Chicago, Illinois
      University of Chicago Medicine
    Jan 25, 2023

    Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA

    Active, not recruiting
    • GCA
    • +3 more
    • Tocilizumab 162Mg/0.9Ml Autoinjector
    • Reggio Emilia, Emilia Romagna, Italy
      Ausl-Irccs - S.C. Di Reumatologia
    May 26, 2022

    Reversibility of Bronchial Obstruction in Children Born Preterm

    Recruiting
    • Bronchopulmonary Dysplasia
    • +6 more
      • Prague, Czechia
        First faculty of Medicine, Charles university.
      Oct 29, 2023